Section 1927 of the Social Security
Act requires drug manufacturers to enter into and have in effect a
rebate agreement with CMS in order for States to receive funding
for drugs dispensed to Medicaid recipients. Drug manufacturers must
explain to States any rebate payment adjustments for the current
quarter, and any prior quarters. The information is used to
reconcile drug rebate payments made by manufacturers with the State
invoices of rebates due.
This package does not propose
any program changes. All forms are unchanged. The total number of
annual burden hours increased for both forms due to an increase in
the number of respondents (manufacturer participation increased
from 610 to 657). The time per response is unchanged. Overall, the
burden has increased by 14,504 hours (from 187,880 hr to 202,384
hr). Cost estimates also increased due to the increase in
manufacturer participation, and because the previous PRA package
inconsistently reflected cost estimates, and did not designate
specific BLS occupational titles and hours to the burden estimates.
This iteration proposes to correct those omissions by setting out
the time and cost estimates for each of the occupational
titles.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.